Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Sentry Investment Management LLC

Sentry Investment Management LLC trimmed its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 13.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 255 shares of the biotechnology company’s stock after selling 41 shares during the quarter. Sentry Investment Management LLC’s holdings in Axon Enterprise were worth $151,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in AXON. Synergy Financial Group LTD increased its holdings in Axon Enterprise by 32.9% in the fourth quarter. Synergy Financial Group LTD now owns 993 shares of the biotechnology company’s stock worth $590,000 after buying an additional 246 shares during the last quarter. IFP Advisors Inc raised its position in shares of Axon Enterprise by 7.6% in the fourth quarter. IFP Advisors Inc now owns 952 shares of the biotechnology company’s stock valued at $566,000 after purchasing an additional 67 shares during the period. Colonial River Investments LLC raised its holdings in Axon Enterprise by 5.5% in the 4th quarter. Colonial River Investments LLC now owns 1,573 shares of the biotechnology company’s stock worth $935,000 after acquiring an additional 82 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its position in Axon Enterprise by 16.2% during the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 12,200 shares of the biotechnology company’s stock worth $7,251,000 after acquiring an additional 1,700 shares during the last quarter. Finally, Howard Capital Management Inc. bought a new position in shares of Axon Enterprise in the fourth quarter worth about $313,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on AXON shares. Robert W. Baird upped their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Northland Securities raised their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $561.31.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $572.40 on Thursday. The firm has a 50 day simple moving average of $613.42 and a 200 day simple moving average of $522.06. Axon Enterprise, Inc. has a fifty-two week low of $265.32 and a fifty-two week high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a market cap of $43.65 billion, a P/E ratio of 147.91, a P/E/G ratio of 5.17 and a beta of 1.05.

Insider Activity

In related news, insider Jeffrey C. Kunins sold 2,304 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the transaction, the insider now owns 128,542 shares of the company’s stock, valued at $84,168,016.18. This trade represents a 1.76 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,711 shares of company stock valued at $5,631,561. Company insiders own 5.70% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.